BIOLASE to Present at the LD Micro Invitational

LOS ANGELES, CA / ACCESSWIRE / June 1, 2016 / BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will be presenting at the 6th annual LD Micro Invitational investor conference in Track 1 at 12:30 PM PDT, Wednesday, June 8, 2016. BIOLASE Senior Vice President and Chief Financial Officer David Dreyer will be giving the presentation and meeting with investors.

The conference will be held from June 7 – 9, 2016, at the Luxe Sunset Bel Air Hotel and will feature 195 small- and micro-cap companies.

To access the BIOLASE Inc. profile prepared by LD Micro, please click on: http://www.ldmicro.com/profile/BIOL

Profiles powered by LD Micro – News Compliments of Accesswire

About BIOLASE, Inc.

BIOLASE, Inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine and also markets, sells, and distributes dental imaging equipment, including digital x-rays and CAD/CAM scanners. BIOLASE’s products are focused on technologies that advance the practice of dentistry to both the dentist and their patients. The Company’s proprietary laser products incorporate approximately 250 patented and 90 patent-pending technologies designed to provide biologically clinically superior performance with less pain and faster recovery times. Its innovative products provide cutting-edge technology at competitive prices to deliver the best results for dentists and patients. BIOLASE’s principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications, and a full line of dental imaging equipment. BIOLASE has sold approximately 31,200 laser systems to date in over 90 countries around the world. Laser products under development address the Company’s core dental market and other adjacent medical and consumer markets.

For updates and information on WaterLase® iPlus™ and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolase, Twitter at www.twitter.com/biolaseinc, LinkedIn at www.linkedin.com/company/biolase, Instagram at www.instagram.com/biolaseinc, and YouTube at www.youtube.com/biolasevideos.

BIOLASE® and WaterLase® are registered trademarks of BIOLASE, Inc.

About LD Micro

LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space. What started out as a newsletter highlighting unique companies has transformed into an event platform hosting several influential conferences annually (Invitational, Summit, and Main Event).

In 2015, LDM launched the first pure microcap index (the LDMi) to exclusively provide intraday information on the entire sector. LD will continue to provide valuable tools for the benefit of everyone in the small and microcap universe.

For those interested in attending, please contact David Scher at david@ldmicro.com or visit www.ldmicro.com for more information.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

Statements made during BIOLASE’s presentation and in its representative’s answers to questions at the 6th annual LD Micro Invitational investor conference (the “Conference”) that refer to BIOLASE’s estimated or anticipated future results or other non-historical facts are forward-looking statements, as are any statements its representatives make at the Conference concerning BIOLASE’s strategic initiatives, anticipated financial performance and product launches. Attendees at the Conference are cautioned not to place undue reliance on these forward-looking statements, which reflect BIOLASE’s current expectations and speak only as of the date of BIOLASE’s participation in the Conference. Actual results may differ materially from BIOLASE’s current expectations depending upon a number of factors affecting BIOLASE’s business including, among others, adverse changes in general economic and market conditions, competitive factors, uncertainty of customer acceptance of new product offerings, risks associated with managing the growth of the business, and those other risks and uncertainties that are described, from time-to-time, in the “Risk Factors” section of BIOLASE’s annual and quarterly reports filed with the Securities and Exchange Commission. BIOLASE does not undertake any responsibility to revise or update any forward-looking statements made during its participation in the Conference.

Contacts:

DresnerAllenCaron
Rene Caron (Investors)
949-474-4300
rcaron@dresnerallencaron.com

Len Hall (Media)
949-474-4300
lhall@dresnerallencaron.com

SOURCE: BIOLASE, Inc. via LD Micro

ReleaseID: 440605